Clinical trials
Phase 3 Gastroesophageal Reflux trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 5 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 3 |
| Eisai Inc. | 2 |
| Takeda | 2 |
| Cogentus Pharmaceuticals | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastroesophageal Reflux | 12 |
| Acute Coronary Syndrome | 1 |
| Cerebrovascular Disorders | 1 |
| Coronary Artery Disease | 1 |
| Coronary Thrombosis | 1 |
| Duodenal Obstruction | 1 |
| Duodenal Ulcer | 1 |
| Dyspepsia | 1 |
| Esophagitis, Peptic | 1 |
| Gastric Outlet Obstruction | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.